The KEYVIBE program: vibostolimab and pembrolizumab for the treatment of advanced malignancies.
Shapira-Frommer R, Niu J, Perets R, Peters S, Shouse G, Lugowska I, Garassino MC, Sands J, Keenan T, Zhao B, Healy J, Ahn MJ.
Shapira-Frommer R, et al. Among authors: healy j.
Future Oncol. 2024;20(27):1983-1991. doi: 10.1080/14796694.2024.2343272. Epub 2024 Sep 4.
Future Oncol. 2024.
PMID: 39230120
Free PMC article.